Granules India Limited (GRANULES.BO) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close794.55

Open799.05

Day range785.00811.00

52-week range412.05811.00

Off day high−2.03%

Off 52-week high−2.03%

Volume134.44K

Avg. volume (3M)40.51K

Market cap192.80B

EPS (TTM)22.49

Forward P/E26.48

P/E ratio (TTM)35.33

Dividend yield0.26% (1.50)

Beta (5Y)-0.02

Shares outstanding242.67M

Short interest—

Earnings dateJul 28, 2025

Analyst target645.71

Profit margin10.71%

Against its peers

Compare in full ›

	GRANULES.BO	IOLCP.NS	IPCALAB.NS	GLAND.NS	THEMISMED.NS	INDSWFTLAB.NS
Market cap	192.80B	55.50B	494.62B	518.99B	9.44B	31.52B
P/E (TTM)	35.3	27.3	37.8	45.9	23.5	37.0
Forward P/E	26.5	17.5	27.7	32.7	—	—
Price/book	4.8	2.9	6.1	5.0	2.4	2.1
Dividend yield	0.26%	0.54%	0.30%	0.63%	0.50%	—
1-year change	+0.63%	+102.86%	+51.13%	+66.39%	−15.87%	+266.59%
Today	−0.01%	+2.89%	−1.14%	−0.44%	+2.13%	−3.72%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Granules India's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
IOL Chemicals and Pharmaceuticals LimitedIOLCP.NS · Drug Manufacturers - Specialty & Generic	55.50B	189.08	+2.89%
Ipca Laboratories LimitedIPCALAB.NS · Drug Manufacturers - Specialty & Generic	494.62B	1,949.60	−1.14%
Gland Pharma LimitedGLAND.NS · Drug Manufacturers - Specialty & Generic	518.99B	3,145.20	−0.44%
Themis Medicare LimitedTHEMISMED.NS · Drug Manufacturers - Specialty & Generic	9.44B	101.64	+2.13%
Ind-Swift Laboratories LimitedINDSWFTLAB.NS · Drug Manufacturers - Specialty & Generic	31.52B	356.75	−3.72%
Morepen Laboratories LimitedMOREPENLAB.NS · Drug Manufacturers - Specialty & Generic	53.21B	97.10	−4.17%
RPG Life Sciences LimitedRPGLIFE.NS · Drug Manufacturers - Specialty & Generic	42.93B	2,595.70	−0.11%
Indoco Remedies LimitedINDOCO.BO · Drug Manufacturers - Specialty & Generic	19.77B	214.50	+0.14%

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company	Mkt cap	Price	Today
AlvotechALVO.IC · Luxembourg, Luxembourg	203.39B	570.00	+2.15%
Hansoh Pharmaceutical Group Company Limited3692.HK · Shanghai, China	213.29B	35.180	+3.11%
FutureChem Co.,Ltd220100.KQ · Seoul, South Korea	185.47B	6,600.00	+0.46%
Whan In Pharm Co.,Ltd.016580.KS · Seoul, South Korea	200.18B	10,830.00	−0.28%
Shilpa Medicare LimitedSHILPAMED.NS · Raichur, India	180.29B	921.80	−1.00%
Daewon Pharmaceutical Co., Ltd.003220.KS · Seoul, South Korea	172.75B	8,060.00	+0.37%
Caplin Point Laboratories LimitedCAPLIPOINT.BO · Chennai, India	184.14B	2,422.55	+0.27%
Swedish Orphan Biovitrum AB (publ)0MTD.IL · Solna, Sweden	178.87B	494.40	+2.47%

Healthcare companies of a similar market value (198.88B).

Company	Mkt cap	Price	Today
Sagility LimitedSAGILITY.NS · Health Information Services	205.04B	43.80	+0.48%
BioMarin Pharmaceutical Inc.BMRN.MX · Biotechnology	197.76B	1,021.00	0.00%
AlvotechALVO.IC · Drug Manufacturers - Specialty & Generic	203.39B	570.00	+2.15%
Hansoh Pharmaceutical Group Company Limited3692.HK · Drug Manufacturers - Specialty & Generic	213.29B	35.180	+3.11%
FutureChem Co.,Ltd220100.KQ · Drug Manufacturers - Specialty & Generic	185.47B	6,600.00	+0.46%
Ain Holdings Inc.9627.T · Pharmaceutical Retailers	206.16B	5,860.00	+5.02%
Create SD Holdings Co., Ltd.3148.T · Pharmaceutical Retailers	216.09B	3,345.00	+4.21%
Illumina, Inc.I1LM34.SA · Diagnostics & Research	187.91B	248.56	−5.04%

Also based in Hyderabad, India, then elsewhere in India.

Company	Mkt cap	Price	Today
Divi's Laboratories LimitedDIVISLAB.BO · Hyderabad, India	2.69T	10,150.00	+1.14%
Laurus Labs LimitedLAURUSLABS.NS · Hyderabad, India	1.27T	2,346.00	+0.96%
Dr. Reddy's Laboratories LimitedDRREDDY.BO · Hyderabad, India	1.13T	1,360.80	−0.82%
Aurobindo Pharma LimitedAUROPHARMA.BO · Hyderabad, India	1.04T	1,788.30	+5.13%
NMDC LimitedNMDC.BO · Hyderabad, India	619.65B	70.48	+0.86%
Gland Pharma LimitedGLAND.NS · Hyderabad, India	518.99B	3,145.20	−0.44%
Premier Energies LimitedPREMIERENE.NS · Hyderabad, India	398.50B	882.50	−2.38%
Bharat Dynamics LimitedBDL.BO · Hyderabad, India	394.42B	1,076.00	−0.09%

Companies that serve the same markets: life sciences, industrial, devices.

Company	Mkt cap	Price	Today
Strides Pharma Science LimitedSTAR.BO · devices · life sciences · industrial	92.73B	1,006.00	−0.58%
Jagsonpal Pharmaceuticals LimitedJAGSNPHARM.BO · devices · life sciences · industrial	14.49B	219.40	−1.08%
Bharat Parenterals LimitedBPLPHARMA.BO · devices · life sciences · industrial	12.56B	1,822.30	+1.16%
Lincoln Pharmaceuticals LimitedLINCOLN.NS · devices · life sciences · industrial	10.27B	512.55	+0.43%
Nectar Lifesciences LimitedNECLIFE.BO · devices · life sciences · industrial	1.97B	10.15	−1.65%
Brooks Laboratories LimitedBROOKS.NS · devices · life sciences · industrial	1.96B	66.45	+1.47%
Parnax Lab LimitedPARNAXLAB.BO · devices · life sciences · industrial	1.18B	103.00	+1.93%
Windlas Biotech LimitedWINDLAS.NS · devices · life sciences · industrial	19.01B	921.25	+5.47%

What visitors to Granules India's page also look at.

Company	Mkt cap	Price	Today
AUROBINDO PHARMA LTD.AUROPHARMA.BO	1.04T	1,788.30	+5.13%
GLENMARK PHARMACEUTICALS LTD.GLENMARK.BO	701.47B	2,485.50	−0.65%
Laurus Labs LimitedLAURUSLABS.BO	1.27T	2,345.00	+1.69%
LUPIN LTD.LUPIN.BO	908.22B	1,987.50	−1.36%
ALEMBIC PHARMACEUTICALS LTD.APLLTD.BO	176.07B	895.75	−1.26%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All GRANULES.BO news ›

BusinessLine·2d agoPositive

Granules India’s Q2 net up 39% at ₹182 crore

Granules India's Q2 net profit rose 39% to â¹182 crore on 20% revenue growth to â¹1,560 crore, amid higher costs and a constructive USFDA audit. Hyderabad, Nov 2 Granules Indiaâs net profit increased 39 per cent at â¹182 crore in the…

Multibagg AI·3d agoNegative

Granules India Limited to Consider Q2 FY27 Results on November 2

Welcome to Multibagg AI Log in to access personalized features Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and…

Multibagg AI·2d agoPositive

Granules India Q2 profit rises 39% as revenue reaches Rs 1,560 crore

Welcome to Multibagg AI Log in to access personalized features Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and…

Multibagg AI·2d agoPositive

Granules India receives Rs 1,096.125 crore on conversion

Welcome to Multibagg AI Log in to access personalized features Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and…

The Hindu·3d agoPositive

Granules India net profit rises 39% to ₹182 cr on higher revenue

Published - November 02, 2026 07:15 pm IST - HYDERABAD Drugmaker Granules India reported 39% year-on-year (YoY) jump in consolidated net profit to ₹181.8 crore in September quarter. The profit came on a 20% YoY increase in revenue from…

Stevens Point·3d agoPositive

Granules India profit surges as higher sales outweigh cost pressures

Nov 2 (Reuters) – Indian drugmaker Granules India reported a second-quarter profit rise of nearly 40% on Monday, as new product launches and ‌strong sales of its main medicines in key overseas markets outweighed higher production costs.…

Free Press Journal·3d agoPositive

Granules India Reports Rs 1,560 Crore Revenue In Q2FY27, Net Cash Reaches Rs 828 Crore

Granules India reported a 39 percent jump in net profit at Rs 181.8 crore for the second quarter ended September 30, 2026, driven by higher operational revenue. The company also announced a net cash position of Rs 828 crore at the end of…

EquityBulls·3d agoPositive

Granules India Ltd reports Q2, H1 FY27 results

02 Nov 2026, 05:52 PM IST Equity Bulls Stock Report Granules India Limited INE101D01020 Financial and Business Summary for Q2FY27 “We recently concluded a US FDA audit at the Gagillapur site, The inspection progressed constructively and…

Informist Media·Oct 24Positive

Informist Media - Earnings Outlook: New product formulation operations to lift Granules India Q2 earnings

Informist, Saturday, Oct. 24, 2026 HYDERABAD – Granules India Ltd. is expected to report healthy growth in the September quarter, led by new product launches in its key business segments, according to analysts. The pharmaceutical company's…

Univest·Oct 16Positive

Granules India Share Price Rise Streak: price, valuation

SUMMARY Granules India Ltd. Share Price Rise Streak is in its second straight session, with the latest traded price at Rs 831.55, up 2.29%, and market capitalisation at Rs 22,039.25 Cr. Granules India Ltd. (GRANULES) rose to Rs 831.55 from…

From the 4Search news index, newest first.

In the news

19mentions in 30 days

19with it in the headline

Positivesentiment

Most coverage from

multibagg.ai5
thehindubusinessline.com3
businessupturn.com1
equitybulls.com1
freedom959.net1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 19 articles, not a forecast.

Key statistics

Against its peers

Related companies

Latest news

In the news

Mentioned with

People in the coverage

Themes

Most coverage from